Supportive therapies 'essential' to mitigate aromatase inhibitor-related adverse effects
Supportive therapies are necessary to help ensure patients adhere to aromatase inhibitor treatment, according to study results presented at San Antonio Breast Cancer Symposium.Further study is necessary to assess the effect that age, race and ethnicity have on treatment duration and use of supportive management, researchers added.